Healthcare networks froze capital expenditures in Q4 2025 to manage their own margin compression. For medical device companies with enterprise sales cycles, that freeze did not just slow revenue. It broke the cash conversion model entirely. You paid your contract manufacturers upfront. The purchase orders did not come. The gap between those two facts is where companies run out of runway.
I am working with a medical device company navigating exactly this situation. The financial restructuring has three moving parts. Each one is manageable. Together they require sequencing.
The core problem is a pricing model built for a different procurement environment
A $150,000 capital expenditure requires committee approval, a capital budget line, and in many hospital systems a board vote. A $5,000 monthly operating expense requires a department head signature. The device is the same. The approval path is different by an order of magnitude. If your pricing model requires the first path and procurement committees are only approving the second, you have a structural mismatch that no amount of sales activity resolves.
What Hardware-as-a-Service actually requires from a finance perspective
The HaaS model sounds simple. In practice it creates three finance problems that need to be solved before you sign the first leasing contract.
Manufacturing cash gap. You still pay your contract manufacturer upfront. Hardware factoring covers that gap by treating your future lease receivables as an asset. Quantify the receivables schedule before you approach a factor.
Revenue recognition. Leasing structures change how and when you recognize revenue under GAAP. The monthly recurring revenue is recognized differently than a point-of-sale transaction. Get this right before you sign contracts, not during your next audit.
Cash flow modeling. A HaaS model front-loads cost and back-loads revenue. Your 13-week cash forecast looks completely different in month one than month twelve. Model both before you commit to the structure.
What we did
We built a side-by-side model comparing the capital sale structure against two HaaS scenarios, one with hardware factoring and one without. It showed break-even month by scenario, minimum contract volume to cover manufacturing, and the cash gap in the first 90 days. That analysis is what the board needed to approve the pricing pivot. It took one week to build.
If your sales cycle depends on capital budget approvals that are not moving, the pricing model may be the bottleneck rather than the sales process. That distinction is worth understanding before you hire more salespeople. Book a strategy call.